These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 10095796

  • 1. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J, Asplund K, Bystedt T, Dahlöf B, Jern S, Kjellström T, Lithell H.
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [Abstract] [Full Text] [Related]

  • 2. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
    Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.
    Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
    [Abstract] [Full Text] [Related]

  • 3. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitán MC, Gil A.
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
    Navarro-Cid J, Maeso R, Perez-Vizcaino F, Casal MC, Cachofeiro V, Ruilope LM, Tamargo J, Lahera V.
    Am J Hypertens; 1996 Jul; 9(7):669-74. PubMed ID: 8806979
    [Abstract] [Full Text] [Related]

  • 5. ACE inhibitor versus beta-blocker for the treatment of hypertension in renal allograft recipients.
    Hausberg M, Barenbrock M, Hohage H, Müller S, Heidenreich S, Rahn KH.
    Hypertension; 1999 Mar; 33(3):862-8. PubMed ID: 10082500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Cabezas-Cerrato J, Garcia-Estevez DA, Araújo D, Iglesias M.
    Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
    [Abstract] [Full Text] [Related]

  • 8. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK, Kjeldsen SE, Motley E, Weder AB, Zweifler AJ, Julius S.
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [Abstract] [Full Text] [Related]

  • 9. Quinapril and blood lipids.
    Koskinen P, Manninen V, Eisalo A.
    Br J Clin Pharmacol; 1988 Oct; 26(4):478-80. PubMed ID: 3190999
    [Abstract] [Full Text] [Related]

  • 10. [Combination antihypertensive therapy in patients with an increased risk profile].
    Bartens W, Nauck M, Wanner C.
    Med Klin (Munich); 1996 Oct 15; 91(10):626-31. PubMed ID: 9019639
    [Abstract] [Full Text] [Related]

  • 11. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 15; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 12. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P, Pörsti I, Pörsti P, Nurmi AK, Seppälä E, Manninen V, Vapaatalo H.
    J Cardiovasc Pharmacol; 1988 Jul 15; 12(1):88-93. PubMed ID: 2459540
    [Abstract] [Full Text] [Related]

  • 13. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.
    Nakagawa H, Daihara M, Tamakawa H, Nozue T, Kawahara K.
    J Cardiovasc Pharmacol; 1999 Jul 15; 34(1):28-33. PubMed ID: 10413063
    [Abstract] [Full Text] [Related]

  • 14. Quinapril treatment enhances vascular sensitivity to insulin.
    Feldman RD, Schmidt ND.
    J Hypertens; 2001 Jan 15; 19(1):113-8. PubMed ID: 11204290
    [Abstract] [Full Text] [Related]

  • 15. Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction.
    Kontopoulos AG, Athyros VG, Papageorgiou AA, Boudoulas H.
    Am J Cardiol; 1999 Nov 15; 84(10):1164-9. PubMed ID: 10569324
    [Abstract] [Full Text] [Related]

  • 16. Analysis of adverse effects among patients with essential hypertension receiving an ACE inhibitor or a beta-blocker.
    Rosenthal J, Bahrmann H, Benkert K, Baumgart P, Bönner G, Klein G, Neiss A, Schnelle K, Frohlich ED.
    Cardiology; 1996 Nov 15; 87(5):409-14. PubMed ID: 8894262
    [Abstract] [Full Text] [Related]

  • 17. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
    Suwelack B, Gerhardt U, Hausberg M, Rahn KH, Hohage H.
    Am J Cardiol; 2000 Sep 01; 86(5):583-5, A10. PubMed ID: 11009288
    [Abstract] [Full Text] [Related]

  • 18. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients.
    Bak JF, Gerdes LU, Sørensen NS, Pedersen O.
    Am J Med; 1992 Apr 27; 92(4B):69S-72S. PubMed ID: 1580283
    [Abstract] [Full Text] [Related]

  • 19. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E, Capurso A, Crepaldi G.
    J Int Med Res; 1993 Apr 27; 21(1):15-25. PubMed ID: 8319817
    [Abstract] [Full Text] [Related]

  • 20. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Romero R, Castellote E, Ocón J, Wagner B.
    J Cardiovasc Pharmacol; 1995 Jul 27; 26(1):114-8. PubMed ID: 7564350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.